By Vince Sullivan ( June 28, 2018, 8:34 PM EDT) -- Bankrupt pharmaceutical company Orexigen Therapeutics Inc. received court approval Thursday in Delaware for a $75 million sale of its assets to stalking horse bidder Nalpropion Pharmaceuticals, bringing to fruition its hopes for a quick transaction in its Chapter 11 case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.